The Future of Animal Health
SustentoBio Inc. is a veterinary biotechnology company dedicated to providing animals with the latest advancements in immunotherapeutics. Using a specially developed protein, our product is able to enhance the animal’s own immune system to fight solid tumors and infectious disease. The treatment is non-invasive, has no known side effects, is cost-effective, and is less painful than the current leading cellular treatment.
We believe pets should have access to the same type of therapies as humans … and at an affordable price.
SUSTENTOBIO: WHAT WE DO
(1) to improve the quality of life for companion animals
(2) to extend the life expectancy of diseased animals
(3) to offer treatments at an affordable price
Solid Tumors, Infectious Disease and Rejuvenation
MARKET: HUMANIZATION OF PETS
Over past two decades, dogs, cats and other companion animals have increasingly become an integral part of the family household.
67% of U.S. households, or about 85 million families own a pet.
95% of owners consider pets part of their family.
In older populations, pets are providing companionship.
In young adult population, pets are replacing the desire to have children.
Greater focus is placed on improving the lifestyle and well-being of pets.
Greater frequency of visits to the veterinarian.
Increased spending on healthcare.
CURRENT CANCER TREATMENTS
Cannot address advanced stage disease
Requires specialized equipment, not readily available
Chemotherapy (CHOP Protocol)
Many side effects, including lethargy
Cost of Treatment: $3,000 to $10,000
Post-Treatment Survival: 6 months